Atomwise and China's Hansoh announce potential $1.5bn AI dru...

Atomwise and Hansoh Pharma have announced an artificial intelligence (AI) drug discovery deal that could be worth $1.5 billion, the largest US-China collaboration in the field.

Mike Page, Alexion Pharmaceuticals invite to SMi's Orphan Dr...

Mike Page, invite to Orphan Drugs & Rare Diseases

AI may not be able to keep up with real-world medicine use, ...

Experts in digital health have published guidance on use of artificial intelligence (AI) in healthcare, warning that the technology may not be able to keep up with how medicines are used in

Novo extends R&D alliance with AI specialist e-Therapeutics

AI specialist Exscientia forms rare disease JV with RallyBio

UK's NHS sitting on patient record gold mine worth billions ...

Patient records held by the UK’s NHS may be worth several billion pounds to commercial organisations, according to a new report.